Integrated meta-analysis, network pharmacology and experimental validation to explore the mechanism of traditional Chinese medicine against neonatal pneumonia: focus on naringenin/MAPK1 - Takeaways - MDSpire

Integrated meta-analysis, network pharmacology and experimental validation to explore the mechanism of traditional Chinese medicine against neonatal pneumonia: focus on naringenin/MAPK1

  • By

  • Bo Gao

  • Bin Zhang

  • Peng Zhang

  • June 4, 2026

  • 0 min

Share

  • 1

    This study systematically analyzed the efficacy of traditional Chinese medicine (TCM) in treating neonatal pneumonia (NP) through meta-analysis and experimental assessment.

  • 2

    A meta-analysis identified a TCM bath formula with significant clinical efficacy, composed of Perilla frutescens, Radix Bupleuri, Mentha haplocalyx, and Schizonepeta tenuifolia.

  • 3

    Naringenin was identified as a key active component, showing strong binding affinity to MAPK1, which plays a role in inflammatory and immune pathways.

  • 4

    In vitro experiments demonstrated that naringenin and MAPK1 knockdown improved cell viability and reduced inflammatory cytokines IL-6, IL-17, and TNF-α.

  • 5

    The findings support the clinical application of TCM in NP, highlighting naringenin's therapeutic effects through targeting MAPK1 and regulating inflammation.

Original Source(s)

Related Content